Hospital Psychiatry - Articles

Expert Q&A

Beyond Meds: TMS in Acute Psychiatric Care

January 1, 2026

Nicholas Trapp, MD, MS

Assistant Professor of Psychiatry; Director, Electroconvulsive Therapy Services, University of Iowa Health Care, Iowa City, IA.

Dr. Trapp has no financial relationships with companies related to this material.

Can TMS be used safely and effectively in the hospital? Dr. Nicholas Trapp shares insights on inpatient protocols, accelerated treatments like SAINT, and how to overcome logistical barriers.

Clinical Update

Transforming Psychiatric Documentation: The Rise of AI Scribes

January 1, 2026

Patrick Buckley, MD, MBA

Patrick Buckley, MD, MBA. Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Dr. Buckley has no financial relationships with companies related to this material.

Tired of documentation dragging into your evenings? Discover how AI scribes are reshaping inpatient psychiatry.

Clinical Update

Telepsychiatry in Hospital Psychiatry: From Stopgap to Standard Care

January 1, 2026

James A. Bourgeois, OD, MD

James A. Bourgeois, OD, MD. Vice Chair, Hospital Psychiatry Services; Professor of Clinical Psychiatry, University of California, Davis Medical Center, Sacramento, CA.

Dr. Bourgeois has no financial relationships with companies related to this material.

Telepsychiatry has moved from rural workaround to hospital mainstay. Whether you're consulting in the ED or rounding remotely, find out what makes this model work and where it can fall apart.

Expert Q&A

AI-Assisted Therapy

January 1, 2026

Omer Liran, MD, MSHS

Co-Director, Cedars-Sinai Virtual Medicine; Assistant Professor, Department of Psychiatry & Behavioral Neurosciences; Co-Founder and CTO, Xaia, Los Angeles, CA.

Dr. Liran is co-founder of Xaia, a company that develops AI-assisted therapy and clinical documentation tools. This content has been peer-reviewed to ensure it remains balanced and educational. Relevant financial relationships have been mitigated.

AI tools are no longer futuristic add-ons—they’re changing how we deliver therapy. Dr. Omer Liran explores the promises and pitfalls of AI-assisted mental health care, from VR-guided relaxation to real-time risk detection.

Research Update

Are We Missing a Potentially Reversible Contributor to Cognitive Impairment?

January 1, 2026

Susan L. Siegfreid, MD

Susan L. Siegfreid, MD. Dr. Siegfreid has no financial relationships with companies related to this material.

Could that “dementia” be liver-related and reversible? A large VA study reveals how often cirrhosis goes undiagnosed in older adults with cognitive decline and why checking a simple fibrosis score might change your diagnosis and your treatment plan.

Research Update

Ketamine Shows Only Modest Advantage Over Midazolam in Inpatient Depression Treatment

January 1, 2026

Victoria Hendrick, MD

Victoria Hendrick, MD. Dr. Hendrick has no financial relationships with companies related to this material.

Is ketamine really more effective than an active placebo for inpatient depression? A new randomized trial puts ketamine head-to-head with midazolam, and the results may temper early enthusiasm.

Research Update

From Acute to Maintenance: The Role of ECT in Long-Term Psychiatric Care

January 1, 2026

Victoria Hendrick, MD

Victoria Hendrick, MD.

Dr. Hendrick has no financial relationships with companies related to this material.

Can continuation and maintenance ECT (c/mECT) reduce hospitalizations and healthcare costs? A large Danish study suggests it can, especially for patients with schizophrenia or treatment-resistant illness. Explore how c/mECT could reshape long-term care planning for your most complex cases.